N. Lynn Henry, MD, PhD is a Professor of Internal Medicine and Interim Division Chief of the Division of Hematology/Oncology. She was formerly section head for breast oncology in the Division of Hematology/Oncology, associate director of Training, Research, and Education for the Rogel Cancer Center, and Co-Director of the Michigan Breast Oncology Quality Consortium. She is also Co-Chair of the Symptom Management and Quality of Life Committee for the SWOG National Cancer Treatment Network research base. She completed her undergraduate training at Louisiana State University, her doctoral degree in structural biology at Stanford University School of Medicine, and her medical degree at Washington University School of Medicine in St Louis, MO. She then completed her internal medicine residency training at Brigham and Women's Hospital in Boston, MA, followed by hematology/oncology fellowship at the University of Michigan. Dr. Henry cares for patients with all types and stages of breast cancer. Her research is focused on toxicity of therapy for patients with breast cancer, including understanding the mechanisms of development of side effects, identifying which patients are likely to tolerate treatment, and examining interventions to manage toxicity. She has received grant funding from the National Cancer Institute, the American Cancer Society, the Damon Runyon Cancer Research Foundation, the V Foundation, the Hope Foundation for Cancer Research, and the Breast Cancer Research Foundation.